Holen Sie sich die Stockscreener-App
13.44
0.67%
-0.07
Schlusskurs vom Vortag:
$13.51
Offen:
$13.62
24-Stunden-Volumen:
610.77K
Relative Volume:
0.69
Marktkapitalisierung:
$1.80B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-151.09M
KGV:
-8.6154
EPS:
-1.56
Netto-Cashflow:
$-160.51M
1W Leistung:
+4.27%
1M Leistung:
-1.40%
6M Leistung:
-20.83%
1J Leistung:
+55.50%
1-Tages-Spanne:
$13.21
$13.84
1-Wochen-Bereich:
$12.55
$13.84
52-Wochen-Spanne:
$7.90
$19.09
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
Firmenname
Centessa Pharmaceuticals Plc Adr
Sektor
Branche
Telefon
44 7391 789784
Adresse
3RD FLOOR, ALTRINCHAM, CHESHIRE
Vergleichen Sie CNTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
13.44 | 1.71B | 0 | -151.09M | -160.51M | -1.56 |
|
ONC
Beone Medicines Ltd Adr
|
245.10 | 25.76B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.93 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.40 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
83.93 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.94 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Eingeleitet | Needham | Buy |
| 2025-05-08 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
| 2024-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-07-18 | Eingeleitet | Oppenheimer | Outperform |
| 2023-11-15 | Hochstufung | Jefferies | Hold → Buy |
| 2023-10-26 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | Eingeleitet | Evercore ISI | Outperform |
| 2023-06-12 | Eingeleitet | Guggenheim | Buy |
| 2023-03-17 | Eingeleitet | SVB Securities | Outperform |
| 2022-08-12 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-06-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Centessa Pharmaceuticals Plc Adr Aktie (CNTA) Neueste Nachrichten
Centessa Pharmaceuticals Announces Executive Changes By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals Announces Executive Changes - Investing.com
Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 Net Loss $0.20 a Share, vs. FactSet Est of $0.37 Loss - marketscreener.com
Centessa Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Is Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) A Suitable Stock For New Investors Today? - Stocksregister
Ratios in Focus: Analyzing Centessa Pharmaceuticals plc ADR (CNTA)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Investor’s Delight: Centessa Pharmaceuticals plc ADR (CNTA) Closes Weak at 13.50, Down -1.53 - DWinneX
Was Centessa Pharmaceuticals plc ADR (CNTA)’s session last reading good? - uspostnews.com
Top investors say Centessa Pharmaceuticals plc ADR (CNTA) ticks everything they need - Sete News
Investor’s Toolkit: Key Ratios for Assessing MSCI Inc (MSCI)’s Performance - DWinneX
Financial Metrics Check: Centessa Pharmaceuticals plc ADR (CNTA)’s Ratios for Trailing Twelve Months - DWinneX
Should investors be concerned about Centessa Pharmaceuticals plc ADR (CNTA)? - uspostnews.com
Parsons Corp (PSN) Shares Up Despite Recent Market Volatility - News Heater
Lantheus Holdings Inc [LNTH] Insider Activity: An Update for Investors - knoxdaily.com
Piper Sandler Initiates Centessa Pharmaceuticals at Overweight With $38 Price Target - MarketScreener
Centessa Pharmaceuticals chief business officer sells $163,386 in stock - Investing.com
Centessa Pharmaceuticals CEO sells shares worth $918,060 By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals CEO sells shares worth $918,060 - Investing.com India
Centessa Pharmaceuticals CAO sells shares worth $120,205 By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals CAO sells shares worth $120,205 - Investing.com India
Centessa Pharmaceuticals’ general counsel sells $98,697 in stock - Investing.com
Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - Stocks Register
Ratios Revealed: Decoding Centessa Pharmaceuticals plc ADR (CNTA)’s Financial Health - The Dwinnex
Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight - GlobeNewswire Inc.
Centessa Pharmaceuticals officer sells shares worth $588,943 - Investing.com India
Aegon Ltd (AEG) looking to reclaim success with recent performance - SETE News
Adversity is less terrifying than hope: Wayfair Inc (W) - SETE News
Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News
Taking the lead: Centessa Pharmaceuticals plc ADR (CNTA) - SETE News
Centessa Pharmaceuticals plc ADR (CNTA) Volatility Hits 6.67%: What Good Investors Need To Be Aware Of - Stocks Register
RLI Corp’s (RLI) Stock: A Week-by-Week Analysis - The News Heater
Centessa Pharmaceuticals plc ADR (CNTA) Shares Up Despite Recent Market Volatility - The News Heater
Aon plc (AON) Stock: Evaluating the Market Performance - The News Heater
Qudian Inc ADR (QD) Stock: A Look at the Analyst Recommendations - The News Heater
Examining the Volatility of Costamare Inc’s (CMRE) Stock - The News Heater
Centessa Pharmaceuticals officer Tia Bush sells $185,406 in shares - Investing.com
Financial Fitness Check: Examining Magna International Inc (MGA)’s Key Ratios - The Dwinnex
Financial Metrics Exploration: Understanding Oncolytics Biotech, Inc (ONCY) Through Ratios - The Dwinnex
Financial Health Report: EyePoint Pharmaceuticals Inc (EYPT)’s Ratios Tell a Tale - The Dwinnex
A closer look at Centessa Pharmaceuticals plc ADR (CNTA) is warranted - US Post News
Centessa Pharmaceuticals chief business officer sells shares worth $193,429 - Investing.com India
Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com
Centessa Pharmaceuticals general counsel Hussain Iqbal sells $91,740 in shares - Investing.com
Centessa Pharmaceuticals appoints new Chief Medical Officer - Investing.com
Centessa Pharmaceuticals' chief business officer sells shares worth $170,399 - Investing.com
Centessa Pharmaceuticals CEO sells $959,057 in shares - Investing.com India
Centessa Pharmaceuticals general counsel sells shares for $1.27 million By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals general counsel sells shares for $1.27 million - Investing.com
Stock Market Recap: Tencent Music Entertainment Group ADR (TME) Concludes at 11.30, a -5.68 Surge/Decline - The Dwinnex
Banzai International Inc (NASDAQ: BNZI): Getting A Free Pass? - Stocks Register
Metrics That Matter About Credo Technology Group Holding Ltd (NASDAQ: CRDO) - Stocks Register
Finanzdaten der Centessa Pharmaceuticals Plc Adr-Aktie (CNTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Centessa Pharmaceuticals Plc Adr-Aktie (CNTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Weinhoff Gregory M | Chief Business Officer |
May 27 '25 |
Sale |
12.82 |
10,000 |
128,225 |
122,279 |
1.76%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):